Concepedia

James Watters

JW

28

Publications

2.6K

Citations

23

H-Index

1998

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Washington University in St. Louis

Harvard University

United States Military Academy

AVEO Oncology (United States)

James Watters is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, tumor biology, and radiation oncology.

ORCID

Top concepts

Publications per year

1998–2024

28

Publications

28

Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors

Ian E. Krop, Tim Demuth, Tina Guthrie et al. · Journal of Clinical Oncology · 2012 · 314 citations · Full text

EMT is the dominant program in human colon cancer

Andre Loboda, Michael Nebozhyn, James Watters et al. · BMC Medical Genomics · 2011 · 276 citations · Full text

MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts

N.V. Rajeshkumar, Elizabeth De Oliveira, Niki A. Ottenhof et al. · Clinical Cancer Research · 2011 · 274 citations · Full text

Comparative expression pathway analysis of human and canine mammary tumors

Paolo Uva, Luigi Aurisicchio, James Watters et al. · BMC Genomics · 2009 · 191 citations · Full text

Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter™ Assay System

Vladislav A. Malkov, Kyle Serikawa, NOEL BALANTAC et al. · BMC Research Notes · 2009 · 173 citations · Full text

Rows per page

1–5 of 28